{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:18:50Z","timestamp":1789676330662,"version":"4.0.1"},"reference-count":50,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Radioiodine\u2010131 (I131) therapy for differentiated thyroid cancer (DTC) is generally a safe and effective treatment, but it has some potential side effects, which have been well described in adults but less analyzed in children. Our aim was to describe early and late adverse events of radioactive I131 in pediatric patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All consecutive patients \u226418 years treated for DTC in the period 1980\u20132015 were retrospectively analyzed for early and late side effects of radioiodine. Early side effects include nausea\/emesis, radiation thyroiditis, sialadenitis, dry mouth, and transient bone marrow (BM) suppression. Late complications include permanent salivary gland dysfunction, permanent BM suppression, pulmonary fibrosis, second cancers, and fertility problems.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred five pediatric patients were treated with I131 for DTC in our department for a total amount of 302 radioiodine treatments. In total, 127 early complications were recorded: 44 episodes of nausea\/emesis; 30 sialoadenitis, 24 thyroiditis, 18 dry mouth, and 11 transient BM suppression. Early side effects were correlated with the amount of radioactivity administered in any treatment. Twelve children developed \u22651 late complication for a total of 20 complications: two permanent salivary gland dysfunction, four permanent BM suppression, five pulmonary fibrosis, four second malignancies, and five fertility alterations. Late events, except fertility alterations, were correlated with the number of therapies and cumulative activities of I131.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In conclusion, early side effects of I131 are associated with the amount of administrated activities of each treatment, while the late effects are correlated with the number of treatments and cumulative activities of radioiodine, except for fertility problems.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.26595","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T12:25:45Z","timestamp":1493036745000},"source":"Crossref","is-referenced-by-count":55,"title":["Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer"],"prefix":"10.1002","volume":"64","author":[{"given":"Domenico","family":"Albano","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department Spedali Civili Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department Spedali Civili Brescia  Brescia Italy"},{"name":"Nuclear Medicine Department University of Brescia and Spedali Civili Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatrice","family":"Panarotto","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department Spedali Civili Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Giubbini","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department Spedali Civili Brescia  Brescia Italy"},{"name":"Nuclear Medicine Department University of Brescia and Spedali Civili Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"BernsteinL GurneyJG. Carcinomas and other malignant epithelial neoplasms. ICCCXI. Pediatric Monograph. In: Ries LAG Smith MA Gurney JG et\u00a0al. eds.Cancer Incidence and Survival Among Children and Adolescents. United States SEER Program 1975\u20131995. National Cancer Institute SEER Program NIH Pub. No. 99\u20104649. Bethesda MD: National Cancer Institute; 1999:11."},{"key":"e_1_2_7_3_1","unstructured":"RiesLAG HarkinsD KrapchoM et\u00a0al.SEER Cancer Statistics Review 1975\u2010\u20102003. [Based on November 2005 SEER data posted to the SEER Web site]. Bethesda MD: National Cancer Institute. http:\/\/seer.cancer.gov\/csr1975_2003. 2006:10."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0460"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2015.10.006"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000250"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1946.02870490016004"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440180017002"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1139"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0403"},{"key":"e_1_2_7_11_1","first-page":"1551","article-title":"Intermediate and long term side effects of high\u2010dose radioiodine therapy for thyroid cancer","volume":"39","author":"Alexander C","year":"1998","journal-title":"J Nucl Med"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.09.001"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2246"},{"issue":"1","key":"e_1_2_7_14_1","first-page":"1","article-title":"EANM' 16","volume":"43","author":"Albano D","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-88441-7"},{"key":"e_1_2_7_16_1","unstructured":"National Cancer Institute.Common Terminology Criteria for Adverse Events (CTCAE v. 4.03). Washington DC: National Cancer Institute; 2010. Accessed January 6 2012."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.1611"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-59-697-45"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-59-702-583"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020210"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.061382"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0466"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108586"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1303-x"},{"key":"e_1_2_7_25_1","first-page":"171","article-title":"The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer","volume":"87","author":"Benua RS","year":"1962","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601319"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1154"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/1096-911X(200007)35:1<41::AID-MPO7>3.0.CO;2-7"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0364-0"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010715)92:2<225::AID-CNCR1313>3.0.CO;2-B"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2009"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7605-z"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2006.19.12.1377"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1841-x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03222.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03081.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.78.916.92"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303556"},{"key":"e_1_2_7_39_1","first-page":"21","article-title":"Assessment of female fertility and carcinogenesis after iodine\u2010131 therapy for differentiated thyroid carcinoma","volume":"36","author":"Dottorini ME","year":"1995","journal-title":"J Nucl Med"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.046599"},{"key":"e_1_2_7_41_1","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1210\/jcem.86.8.7719","article-title":"131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study","volume":"86","author":"Ceccarelli C","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.667"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.t01-1-01545.x"},{"key":"e_1_2_7_44_1","first-page":"1418","article-title":"Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine","volume":"35","author":"Pacini F","year":"1994","journal-title":"J Nucl Med"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01611.x"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1089\/105072503321582060"},{"key":"e_1_2_7_47_1","first-page":"261","article-title":"Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?","volume":"46","author":"Nakada K","year":"2005","journal-title":"J Nucl Med"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1532-z"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0429"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0236"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169888"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.26595","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.26595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T03:35:33Z","timestamp":1696476933000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.26595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1002\/pbc.26595"],"URL":"https:\/\/doi.org\/10.1002\/pbc.26595","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"article-number":"e26595"}}